Hofheim am Taunus, Germany

Johann Ostermeier

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1985.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Johann Ostermeier: Innovator in Azo Pigment Formulations

Introduction

Johann Ostermeier is a notable inventor based in Hofheim am Taunus, Germany. He has made significant contributions to the field of pigment formulations, particularly through his innovative work on azo pigments. His expertise and creativity have led to the development of formulations that enhance the quality and usability of pigments in various applications.

Latest Patents

Ostermeier holds 1 patent for his work on intense azo pigment formulations. This patent focuses on creating azo pigment formulations that exhibit good flow and are readily dispersible. The innovation involves the addition of a long-chain aliphatic primary amine and a diamine of a specific formula, which improves the performance of the pigments.

Career Highlights

Throughout his career, Johann Ostermeier has been associated with Hoechst Aktiengesellschaft, a prominent company in the chemical industry. His work has contributed to advancements in pigment technology, making a lasting impact on the industry. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Ostermeier has collaborated with notable colleagues, including Peter Dopfer and Siegfried Schwerin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Johann Ostermeier's contributions to azo pigment formulations exemplify the spirit of innovation in the chemical industry. His work continues to influence the development of high-quality pigments, showcasing the importance of creativity and collaboration in scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…